Eli Lilly to Taking COVID-19 Antibody Treatment Directly to Nursing Homes

View Transcript
August 7, 2020
With coronavirus affecting the senior population particularly hard, the pharmaceutical company Eli Lilly is launching a COVID-19 antibody treatment study focused on those in assisted living facilities.
We use cookies and similar technologies on this site to collect identifiers, such as IP address, and cookie and device IDs as described in our Privacy Policy.